Search Results - Craig B. Langman

Refine Results
  1. 1
    Critical appraisal of eculizumab for atypical hemolytic uremic syndrome

    Critical appraisal of eculizumab for atypical hemolytic uremic syndrome by Craig B. Langman, Lílian Monteiro Pereira Palma

    Published 2016
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Serum Soluble Urokinase-Type Plasminogen Activator Receptor Levels and Idiopathic FSGS in Children

    Serum Soluble Urokinase-Type Plasminogen Activator Receptor Levels and Idiopathic FSGS in Children by Margret Bock, Heather E. Price, Lorenzo Gallon, Craig B. Langman

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Chlorthalidone promotes mineral retention in patients with idiopathic hypercalciuria

    Chlorthalidone promotes mineral retention in patients with idiopathic hypercalciuria by Fredric L. Coe, Joan H. Parks, David A. Bushinsky, Craig B. Langman, Murray J. Favus

    Published 1988
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure

    Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure by Bernd Höppe, Markus J. Kemper, Arend Bökenkamp, Anthony A. Portale, Richard A. Cohn, Craig B. Langman

    Published 1999
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Maternal BMI Associations with Maternal and Cord Blood Vitamin D Levels in a North American Subset of Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Participants

    Maternal BMI Associations with Maternal and Cord Blood Vitamin D Levels in a North American Subset of Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Participants by Jami L. Josefson, Anna C. Reisetter, Denise Scholtens, Heather E. Price, Boyd E. Metzger, Craig B. Langman

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    A Double-Blind, Placebo Controlled, Randomized Phase 1 Cross-Over Study with ALLN-177, an Orally Administered Oxalate Degrading Enzyme

    A Double-Blind, Placebo Controlled, Randomized Phase 1 Cross-Over Study with ALLN-177, an Orally Administered Oxalate Degrading Enzyme by Craig B. Langman, Danica Grujić, R.M. Pease, Linda Easter, J. Nezzer, Alexey L. Margolin, Lee Brettman

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Folic Acid Therapy and Cardiovascular Disease in ESRD or Advanced Chronic Kidney Disease

    Folic Acid Therapy and Cardiovascular Disease in ESRD or Advanced Chronic Kidney Disease by Xianhui Qin, Yong Huo, Craig B. Langman, Fan Fan Hou, Yundai Chen, Debora Matossian, Xiping Xu, Xiaobin Wang

    Published 2010
    Get full text
    Revisão
    Save to List
    Saved in:
  8. 8
    Transplantation Outcomes in Primary Hyperoxaluria

    Transplantation Outcomes in Primary Hyperoxaluria by Erik J. Bergstralh, Carla G. Monico, John C. Lieske, Regina M. Herges, Craig B. Langman, Bernd Hoppe, Dawn S. Milliner

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Maternal Obesity and Vitamin D Sufficiency Are Associated with Cord Blood Vitamin D Insufficiency

    Maternal Obesity and Vitamin D Sufficiency Are Associated with Cord Blood Vitamin D Insufficiency by Jami L. Josefson, Joseph Feinglass, Alfred Rademaker, Boyd E. Metzger, Dinah M. Zeiss, Heather E. Price, Craig B. Langman

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Hypophosphatemia with Elevations in Serum Fibroblast Growth Factor 23 in a Child with Jansen’s Metaphyseal Chondrodysplasia

    Hypophosphatemia with Elevations in Serum Fibroblast Growth Factor 23 in a Child with Jansen’s Metaphyseal Chondrodysplasia by Whitney W. Brown, Harald Jüppner, Craig B. Langman, Heather E. Price, Emily Farrow, Kenneth E. White, Kenneth McCormick

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Constitutively Activated Receptors for Parathyroid Hormone and Parathyroid Hormone–Related Peptide in Jansen's Metaphyseal Chondrodysplasia

    Constitutively Activated Receptors for Parathyroid Hormone and Parathyroid Hormone–Related Peptide in Jansen's Metaphyseal Chondrodysplasia by Ernestina Schipani, Craig B. Langman, A. M. Parfitt, Geoffrey S. Jensen, Satoru Kikuchi, Sang Whay Kooh, William G. Cole, Harald Jüppner

    Published 1996
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    A Novel Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Mutation in Jansen’s Metaphyseal Chondrodysplasia<sup>1</sup>

    A Novel Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Mutation in Jansen’s Metaphyseal Chondrodysplasia<sup>1</sup> by Ernestina Schipani, Craig B. Langman, Joy L. Hunzelman, M. Le Merrer, Kah Yin Loke, Michael J. Dillon, Caroline Silve, Harald Jüppner

    Published 1999
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Cysteamine bitartrate delayed‐release capsules control leukocyte cystine levels and promote statural growth and kidney health in an open‐label study of treatment‐naïve patients &lt;6 years of age with nephropathic cystinosis

    Cysteamine bitartrate delayed‐release capsules control leukocyte cystine levels and promote statural growth and kidney health in an open‐label study of treatment‐naïve patients &lt... by María Helena Vaisbich, Juliana Caires de Oliveira Achili Ferreira, Heather E. Price, Kyleen D. Young, Saba Sile, Gregg Checani, Craig B. Langman

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Diagnostic delay is common among patients with hypophosphatasia: initial findings from a longitudinal, prospective, global registry

    Diagnostic delay is common among patients with hypophosphatasia: initial findings from a longitudinal, prospective, global registry by Wolfgang Högler, Craig B. Langman, Hugo Gomes da Silva, Shona Fang, Agnès Linglart, Keiichi Ozono, Anna Petryk, Cheryl R. Greenberg, Lothar Seefried, Priya S. Kishnani

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Increased Risk of Fracture in Patients Receiving Solid Organ Transplants

    Increased Risk of Fracture in Patients Receiving Solid Organ Transplants by Rosalind Ramsey‐Goldman, Julie E. Dunn, Dorothy D. Dunlop, Frank P. Stuart, Michaël Abécassis, Dixon B. Kaufman, Craig B. Langman, Michael H. Salinger, Stuart M. Sprague

    Published 1999
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Adherence to the 2017 Clinical Practice Guidelines for Pediatric Hypertension in Safety-Net Clinics

    Adherence to the 2017 Clinical Practice Guidelines for Pediatric Hypertension in Safety-Net Clinics by Allison J. Carroll, Yacob G. Tedla, Roxane Padilla, Arjit Jain, Eduardo Segovia, Anoosh Moin, Andrea S. Wallace, Olutobi Adekunle Sanuade, Craig B. Langman, Nivedita Mohanty, Justin D. Smith

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    A Randomized Controlled Crossover Trial with Delayed-Release Cysteamine Bitartrate in Nephropathic Cystinosis

    A Randomized Controlled Crossover Trial with Delayed-Release Cysteamine Bitartrate in Nephropathic Cystinosis by Craig B. Langman, Larry A. Greenbaum, Minnie Sarwal, Paul C. Grimm, Patrick Niaudet, Georges Deschênes, Marlies Cornelissen, Denis Morin, Pierre Cochat, Debora Matossian, Ségolène Gaillard, Mary Jo Bagger, Patrice Rioux

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Pathophysiology and Treatment of Enteric Hyperoxaluria

    Pathophysiology and Treatment of Enteric Hyperoxaluria by Celeste Witting, Craig B. Langman, Dean G. Assimos, Michelle A. Baum, Annamaria Kausz, Dawn S. Milliner, Gregory E. Tasian, Elaine M. Worcester, Meaghan Allain, Melissa West, Felix Knauf, John C. Lieske

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  19. 19
    25‐hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosus

    25‐hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosus by Peggy Wu, Elisa Y. Rhew, Alan R. Dyer, Dorothy D. Dunlop, Craig B. Langman, Heather E. Price, Kim Sutton‐Tyrrell, David D. McPherson, Daniel Edmundowicz, George T. Kondos, Rosalind Ramsey‐Goldman

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Safety, pharmacodynamics, and exposure-response modeling results from a first-in-human phase 1 study of nedosiran (PHYOX1) in primary hyperoxaluria

    Safety, pharmacodynamics, and exposure-response modeling results from a first-in-human phase 1 study of nedosiran (PHYOX1) in primary hyperoxaluria by Bernd Höppe, Annelize Koch, Pierre Cochat, Sander F. Garrelfs, Michelle A. Baum, Jaap W. Groothoff, Graham Lipkin, Martin Coenen, Gesa Schalk, Aniruddha Amrite, David McDougall, Kelly Barrios, Craig B. Langman

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: